Current Pharmaceutical Designжурнал

Редколлегия

---

• Завьялова Елена Геннадиевна, с 15 октября 2017

Статьи, опубликованные в журнале стиль:  обычный | ГОСТ | plain | abbrv | acm | alpha | amsalpha | amsplain | apalike | ieeetr | siam

---

• 
  • 2016 Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas
  • Chistiakov D.A., Chekhonin I.V., Gurina O.I., Bobryshev Y.V., Chekhonin V.P.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 22, № 37, с. 5378-5751
• 
  • 2016 Aptamers to hemagglutinin: a novel tool for influenza virus recognition and neutralization
  • Zavyalova E., Kopylov A.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 22, № 31, с. 4835-4853 DOI
• 
  • 2016 Development of antithrombotic aptamers: from recognizing elements to drugs
  • Zavyalova E., Golovin A., Pavlova G., Kopylov A.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 22, № 33, с. 5163-5176 DOI
• 
  • 2016 Prospects of Developing Medicinal Therapeutic Strategies and Pharmaceutical Design for Effective Gluten Intolerance Treatment
  • Savvateeva Lyudmila V., Zamyatnin Andrey A.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 22, № 16, с. 2439-2449 DOI
• 
  • 2016 RGD-based Therapy: Principles of Selectivity
  • Rubtsov Mikhail A., Syrkina Marina S., Gjumrakch Aliev
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 22, № 7, с. 925-932 DOI
• 
  • 2015 Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets
  • Slastnikova T.A., Rosenkranz A.A., Zalutsky M.R., Sobolev A.S.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 21, № 9, с. 1227-1238 DOI
• 
  • 2013 Glycogen synthase kinase 3 as an anticancer drug target: Novel experimental findings and trends in the design of inhibitors
  • Osolodkin DI, Palyulin VA, Zefirov NS
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 19, № 4, с. 665-679 DOI
• 
  • 2013 Immunogenicity and protective efficacy of candidate universal Influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors
  • Petukhova N.V., Gasanova T.V., Stepanova L.A., Rusova O.A., Potapchuk M.V., Korotkov A.V., Skurat E.V., Tsybalova L.M., Kiselev O.I., Ivanov P.A., Atabekov J.G.
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 19, № 31, с. 5587-5600 DOI
• 
  • 2013 Novel penetrating cations for targeting mitochondria
  • Chernyak BV, Antonenko YN, Domnina LV, Ivanova OY, Lyamzaev KG, Pustovidko AV, Rokitskaya TI, Severina II, Simonyan RA, Trendeleva TA
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 19, № 15, с. 2795-2806 DOI
• 
  • 2013 Novel penetrating cations for targeting mitochondria
  • Chernyak BV, Antonenko YN, Domnina LV, Ivanova OY, Lyamzaev KG, Pustovidko AV, Rokitskaya TI, Severina II, Simonyan RA, Trendeleva TA, Zvyagilskaya RA
  • в журнале Current Pharmaceutical Design, издательство Bentham Science Publishers (Netherlands), том 19, № 15, с. 2795-2806